TWP
AVNS

TFO Wealth Partners’s Avanos Medical AVNS Stock Holding History

TFO Wealth Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6
Closed -$153 – 945
2023
Q3 		$153 Buy
+6
New +$136 ﹤0.01% 906
2020
Q1 		– Sell
-33
Closed -$1K – 128
2019
Q4 		$1K Buy
+33
New +$1.2K ﹤0.01% 137

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TFO Wealth Partners's AVNS Position: Q4 2023 in Review

TFO Wealth Partners sold out of Avanos Medical (AVNS) in Q4 2023, closing a stake of 6 shares — an estimated $153 sold.

TFO Wealth Partners first reported a position in AVNS in Q4 2019 and held it in 2 quarters. The position peaked at $1K in Q4 2019. 265 funds tracked by Wall St. Rank hold AVNS as of Q4 2023.

  • TFO Wealth Partners reported no remaining Avanos Medical position as of Q4 2023 after selling out during the quarter.
  • TFO Wealth Partners sold 6 Avanos Medical shares in Q4 2023, an estimated $153.
  • TFO Wealth Partners first reported a position in Avanos Medical in Q4 2019 and held it in 2 quarters.
  • TFO Wealth Partners's Avanos Medical position peaked at $1K in Q4 2019.
  • 265 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2023.

Based on TFO Wealth Partners's 13F filing for Q4 2023, filed 12 Feb 2024.